This is a prospective phase II study of peri-operative docetaxel plus laparoscopic radical prostatectomy in patients with localized Gleason 7 pT2a-pT2b adenocarcinoma of the prostate and a risk of relapse after radical prostatectomy.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
37
Institut Gustave Roussy
Villejuif, France
Complete prostate specific antigen (PSA) response rate
Toxicity
Pathological response rate
Progression free survival
Overall survival
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.